HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,210,000 | -1.6% | 952,393 | +5.6% | 0.04% | +8.3% |
| Q2 2023 | $31,725,000 | +17.3% | 901,528 | +8.8% | 0.04% | +12.5% |
| Q1 2023 | $27,056,000 | -30.1% | 828,669 | +18.0% | 0.03% | -30.4% |
| Q4 2022 | $38,685,000 | +32.0% | 702,094 | +6.2% | 0.05% | +27.8% |
| Q3 2022 | $29,296,000 | -4.7% | 660,844 | +4.9% | 0.04% | +2.9% |
| Q2 2022 | $30,736,000 | +55.9% | 630,211 | +55.5% | 0.04% | +133.3% |
| Q1 2022 | $19,721,000 | – | 405,368 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |